HBAN
62
3
ACN
33
4
SE
74
3
NTRS
39
-11
SPG
45
5
MS
65
14
TGNA
67
3
WBA
45
-2
DNB
60
2
V
46
2
LNC
58
2
HOG
45
2
EMR
60
4
FRT
50
4
MET
73
4
SBUX
47
3
DE
62
2
MTCH
51
5
WMT
55
5
PG
68
4
HBAN
62
3
ACN
33
4
SE
74
3
NTRS
39
-11
SPG
45
5
MS
65
14
TGNA
67
3
WBA
45
-2
DNB
60
2
V
46
2
LNC
58
2
HOG
45
2
EMR
60
4
FRT
50
4
MET
73
4
SBUX
47
3
DE
62
2
MTCH
51
5
WMT
55
5
PG
68
4
Financhill
Back

Agios Pharmaceuticals Stock Predictions

The Tariff-Proof Asset in Your Pocket

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
28

AGIO
Agios Pharmaceuticals

Last Price:
$31.24
Seasonality Move:
9.03%

7 Day Trial

ALL ACCESS PASS

$ 7

Your Data Made Them Billions-Now It's Your Turn to Profit

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Agios Pharmaceuticals Stock Forecast

  • Over the next 52 weeks, Agios Pharmaceuticals has on average historically risen by 10.9% based on the past 11 years of stock performance.
  • Agios Pharmaceuticals has risen higher in 6 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 54.55%
  • Is Agios Pharmaceuticals Stock Undervalued?
    The current Agios Pharmaceuticals [AGIO] share price is $31.99. The Score for AGIO is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • AGIO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Agios Pharmaceuticals Stock Go Up Next Year?

  • Over the next 52 weeks, Agios Pharmaceuticals has on average historically risen by 10.9% based on the past 11 years of stock performance.

Agios Pharmaceuticals Stock Rating

Sell
28
Agios Pharmaceuticals (AGIO) is a Sell

Is Agios Pharmaceuticals overpriced?

  • Agios Pharmaceuticals has risen higher in 6 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 54.55%

Agios Pharmaceuticals Stock Price History

Is AGIO stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AGIO is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
agios.com

52-Week Data

52-Week High:
62.58
52-Week Low:
27.14

Prediction Charts

Market Cap:
1.8B
Price in USD:
31.99
Volume:
624.9K
Beta:
1.31

Technical Analysis

SMA50:
33.56
SMA100:
41.19
SMA200:
42.79
52-Wk Change:
6.85%

Stock Predictions

  • Is Agios Pharmaceuticals stock public?
    Yes, Agios Pharmaceuticals is a publicly traded company.
  • What is the Agios Pharmaceuticals stock quote today?
    The Agios Pharmaceuticals stock price is 31.99 USD today.
  • How to buy Agios Pharmaceuticals stock online?
    You can buy Agios Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Feb-25 35.48 35.19 35.75 34.42
Feb-26 35.19 34.44 36.07 34.32
Feb-27 34.51 34.33 35.73 34.31
Feb-28 34.05 35.53 35.54 34.05
Mar-3 35.55 33.12 35.70 32.82
Mar-4 32.60 33.42 33.66 32.47
Mar-5 33.54 33.98 34.30 33.49
Mar-6 33.15 33.98 34.33 33.15
Mar-7 33.80 32.38 34.47 32.32
Mar-11 31.93 32.13 32.52 31.33
Mar-12 32.19 31.98 33.07 31.64
Mar-13 32.00 31.07 32.50 31.02
Mar-14 31.85 30.93 31.85 30.91
Mar-17 30.93 31.99 32.20 30.64

Agios Pharmaceuticals Earnings

Agios Pharmaceuticals Earnings Report: Per Share Agios Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.

Agios Pharmaceuticals Forecast Revenue Growth

Agios Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Agios Pharmaceuticals and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $9.81 per share, a decrease next quarter of $0.00 per share, a decrease this year of $18.40 per share, and an increase next year of $1.39 per share.

* Agios Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.